http://google.brand.edgar-online.com/displayfiling

New Post Public Reply Private Reply Replies (1) Message Board
Msowid
332
http://google.brand.edgar-online.com/displayf...;type=html

This guy, Moscato, is a genius.....amazing that he can convince these three guys ( Lawrence Salvo, Stephen L. Berkman and B-H Sanford, LLC)....to enter into a stock control agreement....and in the process, acquire 33,000,00 shares to sell at any time before Dec. 2019....to pay for R and D, and M and A's, and salaries and other stuff....and the beautiful thing about this, it is doable.....you have 33,000,000 shares that can be exercise able within the year to generate millions and millions of dollars (at $ 2.50/ share) to keep the company afloat for many years to come....to make THEM and US richer than ever b4....even people that bought at 25. $ will more than double their investment in a very short time....even old timers like me, after suffering a 1000:1 reverse split, can now believe in the power of speculative stock picking.....
I tip my hat to this, Moscato, ....I used to read him at the digitalboard b4 he was CEO....and I more than liked his talk....but now I think he is Trumpian.....he can make the impossible possible...

p.s. on top of that these three guys believe in this Moscato so much that they have made him attorney in charge to dispose of such shares at his discretion whenever needed...."....each of the named stockholders has agreed to name Mr. Moscato as proxy in connection with the voting of any of these shares during the term of the Stock Control Agreement. The term of the Stock Control Agreement will terminate on December 1, 2019."

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vylor's $3 Billion Buyback: A Long-Term Bet

Updated Category News Views 7

Pumping Confidence with a Massive Buyback Vylor's big move to throw $3 billion into a share buyback isn't about short-term antics. This company's doubling down on long-term value creation, making sure every stakeholder knows they're in for the long haul. It's a gutsy move but what this step really tells us is, they've got faith in the business and a balance sheet that can...

Continue Reading
Anavex Faces Securities Lawsuit: Investor Implications

Updated Category News Views 0

Storm Clouds Over Anavex: What Investors Need to Know If you've got a slice of Anavex Life Sciences Corp. (NASDAQ: AVXL) in your portfolio, the latest chapter of their legal saga feels less like a twist and more like a twist of the knife. These lawsuits often come out of left field for investors, but this one seems like a slow train that’s been gathering steam for a...

Continue Reading
Tigo Energy Faces Class Action Over Revenue Claims

Updated Category News Views 4

Trouble Brewing for Tigo Energy? Straight from the horse's mouth, we hear about Tigo Energy (NASDAQ: TYGO) getting embroiled in a class action smackdown. Picture it: Tigo fumbles their projections, and boy does it sting. They're caught in the crossfire for allegedly puffing up their revenue expectations tied to a venture with EG4 Electronics—poised to churn out...

Continue Reading
WOLFX Super App Surges with 300% Growth Post-Launch

Updated Category News Views 4

A Fast-Paced Entry into the College Scene College life isn’t getting any easier, but the WOLFX app is blazing a trail through U.S. campuses, promising to mend some of the chaos students deal with daily. It's barely taken a breath since launching just a month ago, already knitting itself into the routine of students from 104 universities in 130 cities across America -...

Continue Reading
FuelCell's Class Action: Investors' Deadline Approaching

Updated Category News Views 3

One Rough Ride for FuelCell Investors Sometimes the market feels like a roller coaster stuck on the down-hill plunge, and right now, FuelCell Energy (NASDAQ: FCEL) investors are gripping their harnesses. The latest turmoil has investors looking at a tight November 10 deadline to decide if they want in on the securities class action shaking the ground beneath FCEL. Looming...

Continue Reading
Beyond The Bounce Expands with Pro Pickleball Star

Updated Category News Views 1

Pickleball's Power Play: The Media Move Out of the blue, the world of niche sports finds its hub. Beyond The Bounce steps up to the plate by roping in pickleball’s own Zane Navratil. The hype’s not in the spin here—this is serious business. The company plans to push the boundaries of the sport into mainstream media, or at least give it a decent shot. Zane Navratil:...

Continue Reading
HSG's Laser Tech Dazzles at FABTECH 2026

Updated Category News Views 1

Laser Innovations on Display at FABTECH 2026 Listen up, folks—FABTECH 2026 in Vegas is where HSG Laser decided to flaunt their new toys, codenamed TS2 PRO and the mystical AI CutPilot. Now, unless you've been living under a rock, you'll know HSG is all about shaking up the laser cutting scene. They've done it for two decades, and now they're pushing the envelope with...

Continue Reading
Volvo's Q3 2026 Results: Strong Growth and Margin

Updated Category News Views 4

Volvo Group's Robust Q3 Performance It's not every day that you see a company like Volvo Group churning out results that make you take a second sip of that morning coffee. But here we are—looking at Q3 2026 with growth numbers that pack a punch. You can't argue with SEK 119.5 billion in net sales, especially when organic sales growth hit 7%. That's no small feat in...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 6

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
3Srobotics Breaks Ground with North American Debut

Updated Category News Views 2

3Srobotics Steps Into the Big League The sweltering buzz of FABTECH 2026 in Las Vegas signals more than just another industry tradeshow; it's the stage upon which 3Srobotics made its North American debut. In a span shorter than it takes most companies to get serious about their business cards, 3Srobotics has already nailed three funding rounds, snagging tens of millions...

Continue Reading
class="blog__more"> More News Articles